1-15 of 141
Screening for Significant Fibrosis in Patients with Obesity
GI InsightsScreening for Significant Fibrosis in Patients with Obesity
Fernando Bril, MD
Obesity and Liver Disease: Getting to the Core of Treatment
GI InsightsObesity and Liver Disease: Getting to the Core of Treatment
Fernando Bril, MD
Is Lifestyle Intervention Enough for Obesity and MASLD?
GI InsightsIs Lifestyle Intervention Enough for Obesity and MASLD?
Fernando Bril, MD
The Emerging Role of Triple Agonists in Obesity Management
Clinician's RoundtableThe Emerging Role of Triple Agonists in Obesity Management
Javier Morales, MD, FACP, FACE
Peter Buch, MD, FACG, AGAF, FACP
David Tendler, MD
Personalizing Nutrition and Exercise Alongside GLP-1 Receptor Agonist Therapy
Diabetes DiscoursePersonalizing Nutrition and Exercise Alongside GLP-1 Receptor Agonist Therapy
Laura Chiavaroli, PhD
- advertisement
UACR in Diabetes: A Window Into Cardiorenal Risk
Diabetes DiscourseUACR in Diabetes: A Window Into Cardiorenal Risk
Brian P. McDonough, MD, FAAFP
Jennifer B. Green, MD
Maintaining Weight Loss: Early Evidence on Microbiome-Derived Supplementation
NutritionEdgeMaintaining Weight Loss: Early Evidence on Microbiome-Derived Supplementation
Marlene Mimi Maeusli, PhD.
Hallie Blevins, PhD
Addressing Cardiovascular Risk in Prediabetes: Why Earlier Action Matters
Diabetes DiscourseAddressing Cardiovascular Risk in Prediabetes: Why Earlier Action Matters
John W. Ostrominski, MD, MPH
Enhancing the Metabolic Benefits of GLP-1s with Diet and Exercise
Diabetes DiscourseEnhancing the Metabolic Benefits of GLP-1s with Diet and Exercise
Laura Chiavaroli, PhD
Investigating Beta Cell Dysfunction and Immune Activity in Early T1D
Diabetes DiscourseInvestigating Beta Cell Dysfunction and Immune Activity in Early T1D
Edward Phelps, PhD
Investigating Alpha-Beta Cell Proximity and T-Cell Interactions in T1D
Diabetes DiscourseInvestigating Alpha-Beta Cell Proximity and T-Cell Interactions in T1D
Vira Kravets, PhD
- advertisement
Unanswered Questions in T1D: What Immunology and Islet Research Can Tell Us
Diabetes DiscourseUnanswered Questions in T1D: What Immunology and Islet Research Can Tell Us
Edward Phelps, PhD
Assessing the Evidence for GLP-1 Receptor Agonists in Psoriatic Disease
On the Frontlines of PsoriasisAssessing the Evidence for GLP-1 Receptor Agonists in Psoriatic Disease
Mary Leuchars, MD
Jeffrey Cohen, MD, MPH
The Potential Role of GLP-1s in Psoriatic Arthritis Management
Living RheumThe Potential Role of GLP-1s in Psoriatic Arthritis Management
Philip Mease, MD, MACR